Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Restoril (temazepam) Treatment Report
What is Restoril?

Restoril® is a brand name for temazepam, a benzodiazepine used for the short-term treatment of insomnia. Off label it is used for the treatment of anxiety; adjunct in the treatment of depression; and management of panic attacks.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Insomnia 9 0
Awakening due to pain 4 1
Other 4 1
Sleeplessness 2 0
General health 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  30mg as needed 5mg as needed 7.5 mg daily 15 mg daily 30 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 6 Number of Patients: 6  

Stop Reasons

Why Patients Stopped Taking Restoril (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
2 29% Did not seem to work: 29%
Expense
1 14% Expense: 14%
Personal research
1 14% Personal research: 14%
Doctor's advice
1 14% Doctor's advice: 14%
Other
1 14% Other: 14%
Course of treatment ended
1 14% Course of treatment ended: 14%
Not indicated
1 14% Not indicated: 14%

See all 7 patients who’ve stopped taking Restoril

Currently Taking Restoril

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
2
5
2

Stopped Taking Restoril

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
1
0
2
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.